Leading Companies Reinforcing Their Presence in the Farm Animal Drugs Market

The farm animal drugs industry is positioned for significant expansion as global demand for animal healthcare solutions continues to rise. Factors such as advancements in veterinary medicine, increasing consumer focus on food safety, and strengthened regulatory frameworks are all contributing to this upward trajectory. Below, we explore the market projections, leading companies, emerging trends, and segment analysis shaping this evolving sector.

Projected Market Growth of the Farm Animal Drugs Industry
The farm animal drugs market is set to experience robust growth, reaching a value of $28.88 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 7.1%. Several factors are driving this growth, including a stronger emphasis on antimicrobial stewardship, heightened demand for high-quality animal proteins, improvements in veterinary healthcare infrastructure, and more stringent regulations concerning food safety and animal welfare. Innovations in drug formulations tailored specifically for livestock also play a crucial role. Key trends expected to influence the market during the forecast period include increased demand for preventive veterinary medicines, broader use of combination drug therapies, enhanced focus on food safety and residue compliance, growth in therapeutic treatments for intensive livestock farming, and wider adoption of prescription-based veterinary drugs.

Download a free sample of the farm animal drugs market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12159&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Players Dominating the Farm Animal Drugs Market
The farm animal drugs sector features a range of prominent companies that hold significant market shares. Some of the top players include Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Ceva Santé Animale SA, Virbac SA, Huvepharma Inc., Phibro Animal Health Corporation, and Dechra Pharmaceuticals plc. Additional key companies are Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Neogen Corporation, Ouro Fino Saude Animal Participacoes SA, Eco Animal Health Ltd., Biogenesis Bago SA, Laboratorios Calier S.A., Laboratorios Syva S.A., Jurox Pty Ltd., Kepro B.V., Kyoritsu Seiyaku Corp., Merck Animal Health, Vetoquinol SA, Nippon Zenyaku Kogyo Co. Ltd., SeQuent Scientific Limited, Agrovet Market Animal Health, Orion Pharma Animal Health, and Zydus Animal Health and Investments Limited.

Strategic Acquisitions Strengthening Market Positions
In a notable development in July 2024, MSD Animal Health, a US-based leader in veterinary pharmaceuticals and health management solutions, acquired Elanco Animal Health Incorporated's aqua business. The financial terms of the deal were not disclosed. This acquisition allows Merck Animal Health to broaden its product portfolio and reinforce its standing in the global aquaculture market by introducing an extensive range of fish health and sustainability products, including vaccines, anti-parasitic treatments, nutritionals, and related technologies. Elanco Animal Health is known for its diverse offerings targeting aquatic species, encompassing vaccines and supplements for managing both warm-water and cold-water fish health.

View the full farm animal drugs market report:
https://www.thebusinessresearchcompany.com/report/farm-animal-drugs-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Innovation as a Cornerstone of Growth in Farm Animal Drugs
Leading companies in the farm animal drugs market are actively pursuing new, effective solutions to address common livestock health challenges. One key example is the development of moxidectin injectable solutions designed for parasite control in cattle. Moxidectin serves as an antiparasitic medication that treats both internal and external parasites in cattle. For instance, in March 2023, Norbrook Laboratories Ltd., a UK-based pharmaceutical firm, secured FDA approval for Tauramox-the first generic version of the moxidectin injectable solution used for beef and non-lactating dairy cattle parasite management. Tauramox matches the concentration of the original moxidectin and is available over the counter in 10 mg/ml concentrations, supplied in 250 ml and 500 ml bottles. The recommended dosage is 1 ml per 110 pounds of body weight.

Market Segmentation and Share Analysis in the Farm Animal Drugs Industry
This report categorizes the farm animal drugs market into distinct segments for a detailed outlook:
1) Product Types: Anti-Infective, Parasiticides, Anti-Inflammatory, Anesthetics, Analgesics, Hormones and Related Products, and Other Products
2) Route of Administration: Oral, Parenteral, Topical, and Other Routes
3) Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Other Channels
4) Animal Type: Livestock Animals and Equine

Further subcategories include:
- Anti-Infective: Antibiotics, Antivirals, Antifungals
- Parasiticides: Endectocides, Anthelmintics, Ectoparasiticides
- Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids
- Anesthetics: Local and General Anesthetics
- Analgesics: Opioids and Non-Opioid Analgesics
- Hormones and Related Products: Reproductive Hormones, Growth Promoters, Thyroid Hormones
- Other Products: Vaccines, Nutraceuticals, Diagnostic Products

This segmentation offers a comprehensive view of the market's structure, aiding stakeholders in understanding current demands and future growth opportunities.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.